This inventor holds 1 USPTO granted patent. Top assignee: Beacle, Inc.. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Kentaro Isotani: Innovator in Virus-Like Particle Technology
Introduction
Kentaro Isotani is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of immunology through his innovative work on virus-like particles. His research focuses on developing solutions to combat hepatitis B virus (HBV) infections.
Latest Patents
Kentaro Isotani holds a patent for "Virus-like particles including HBs-L antigen protein for causing immune response against HBV." This invention provides a virus-like particle comprising several types of HBs-L antigen proteins. The goal is to create an antigen that triggers an immune reaction against HBV of various genotypes. This patent represents a crucial advancement in the fight against HBV.
Career Highlights
Kentaro Isotani is associated with Beacle, Inc., where he continues to push the boundaries of scientific research. His work has garnered attention for its potential impact on public health, particularly in the prevention and treatment of viral infections.
Collaborations
Kentaro collaborates with notable colleagues, including Yasumasa Goh and Yasunori Oda. Their combined expertise enhances the research efforts at Beacle, Inc., fostering an environment of innovation and discovery.
Conclusion
Kentaro Isotani's contributions to the field of immunology through his patent on virus-like particles highlight his role as a key innovator. His work not only advances scientific knowledge but also holds promise for improving health outcomes related to HBV.